Orange Book product · Generic (ANDA)
ERYTHROMYCIN ESTOLATE
ERYTHROMYCIN ESTOLATE
At a glance
Oct 17, 1990
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 17, 1990
36 yr 2 mo ago
Today
Pharmaceutical detail
Active ingredient
ERYTHROMYCIN ESTOLATE
Strength
EQ 125MG BASE/5ML
Dosage form
SUSPENSION
Route
ORAL
TE code
Not listed
Application
ANDA 062169
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ERYTHROMYCIN ESTOLATE
- —ILOSONEBrand (NDA)
NDA 050010 · LILLY
- 1982ERYTHROMYCIN ESTOLATEGeneric (ANDA)
ANDA 062362 · LIFE LABS
- 1982ERYTHROMYCIN ESTOLATEGeneric (ANDA)
ANDA 062409 · ALPHARMA US PHARMS
- 1982ERYTHROMYCIN ESTOLATEGeneric (ANDA)
ANDA 062353 · ALPHARMA US PHARMS
- —ERYTHROMYCIN ESTOLATEGeneric (ANDA)
ANDA 062162 · BARR
- —ERYTHROMYCIN ESTOLATEGeneric (ANDA)
ANDA 062237 · IVAX SUB TEVA PHARMS
- —ERYTHROMYCIN ESTOLATEGeneric (ANDA)
ANDA 062087 · WATSON LABS
- —ILOSONEGeneric (ANDA)
ANDA 061897 · LILLY
- —ILOSONEGeneric (ANDA)
ANDA 061893 · DISTA
- —ILOSONEGeneric (ANDA)
ANDA 061894 · LILLY
- —ILOSONEGeneric (ANDA)
ANDA 061895 · DISTA
- —ILOSONEGeneric (ANDA)
ANDA 061896 · LILLY
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
